Inmune Bio, Inc. (INMB) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $32.35M | -18.2% |
| 2024 | $39.56M | -30.6% |
| 2023 | $57.00M | -30.3% |
| 2022 | $81.80M | -18.2% |
| 2021 | $99.94M | +145.8% |
| 2020 | $40.66M | +66.1% |
| 2019 | $24.47M | +40.9% |
| 2018 | $17.36M | -5.7% |
| 2017 | $18.41M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $32.35M | -18.2% |
| 2024 | $39.56M | -30.6% |
| 2023 | $57.00M | -30.3% |
| 2022 | $81.80M | -18.2% |
| 2021 | $99.94M | +145.8% |
| 2020 | $40.66M | +66.1% |
| 2019 | $24.47M | +40.9% |
| 2018 | $17.36M | -5.7% |
| 2017 | $18.41M | — |